Search

Your search keyword '"Kruger, Claire"' showing total 44 results
Start Over Author "Kruger, Claire"
44 results on '"Kruger, Claire"'

8. A randomized, open-label, cross-over pilot study investigating metabolic product kinetics of the palatable novel ketone ester, bis-octanoyl (R)-1,3-butanediol, and bis-hexanoyl (R)-1,3-butanediol ingestion in healthy adults

Author

Stubbs, Brianna J, primary, Cook, Chad, additional, Blonquist, Traci M, additional, Taggart, Kristen, additional, Beckman, Dawn, additional, Kruger, Claire, additional, Conze, Dietrich, additional, and Boileau, Amy C, additional

Published
2023
Full Text
View/download PDF

9. sj-pdf-1-tor-10.1177_23978473211068834 ��� Supplemental Material for Toxicological assessment of truebroc�� glucoraphanin-rich broccoli seed extract

Author

Kruger, Claire, Symonds, Jennifer, and Conze, Dietrich

Subjects
70706 Veterinary Medicine, FOS: Clinical medicine, FOS: Veterinary sciences, 111799 Public Health and Health Services not elsewhere classified, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental Material, sj-pdf-1-tor-10.1177_23978473211068834 for Toxicological assessment of truebroc�� glucoraphanin-rich broccoli seed extract by Claire L Kruger, Jennifer Symonds and Dietrich Conze in Toxicology Research and Application

Published
2022
Full Text
View/download PDF

11. Supplemental_Tables - Toxicological assessment of β-galactosidase shows no adverse effects in vivo and in vitro

Author

Symonds, Jennifer M, Fujita, Tomohiro, Shouhei Aoki, Shiota, Kazuma, and Kruger, Claire L

Subjects
70706 Veterinary Medicine, FOS: Clinical medicine, FOS: Veterinary sciences, 111799 Public Health and Health Services not elsewhere classified, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplemental_Tables for Toxicological assessment of β-galactosidase shows no adverse effects in vivo and in vitro by Jennifer M Symonds, Tomohiro Fujita, Shouhei Aoki, Kazuma Shiota and Claire L Kruger in Toxicology Research and Application

Published
2020
Full Text
View/download PDF

15. Supplementary_Material - In vivo safety evaluation of the Clostridium butyricum MIYAIRI 588 strain in broilers, piglets, and turkeys

Author

Oka, Kentaro, McCartney, Elinor, Ariyoshi, Tadashi, Hayami Kudo, Vilá, Borja, Jong, Lineke De, Kozłowski, Krzysztof, Jankowski, Jan, Morgan, Sarah, Kruger, Claire, and Motomichi Takahashi

Subjects
70706 Veterinary Medicine, FOS: Clinical medicine, FOS: Veterinary sciences, 111799 Public Health and Health Services not elsewhere classified, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplementary_Material for In vivo safety evaluation of the Clostridium butyricum MIYAIRI 588 strain in broilers, piglets, and turkeys by Kentaro Oka, Elinor McCartney, Tadashi Ariyoshi, Hayami Kudo, Borja Vilá, Lineke de Jong, Krzysztof Kozłowski, Jan Jankowski, Sarah Morgan, Claire Kruger, and Motomichi Takahashi in Toxicology Research and Application

Published
2019
Full Text
View/download PDF

18. Supplementary Material, Supplementary_Table_1 - Toxicological assessment of Euglena gracilis strain Eu029 shows no adverse effects in vivo and in vitro

Author

Symonds, Jennifer M, Beauchamp, Nicole, Takeuchi, Takuto, Yamada, Koji, Atsuji, Kohei, Asayama, Yuta, Suzuki, Kengo, and Kruger, Claire L

Subjects
70706 Veterinary Medicine, FOS: Clinical medicine, FOS: Veterinary sciences, 111799 Public Health and Health Services not elsewhere classified, FOS: Health sciences, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
Abstract

Supplementary Material, Supplementary_Table_1 for Toxicological assessment of Euglena gracilis strain Eu029 shows no adverse effects in vivo and in vitro by Jennifer M Symonds, Nicole Beauchamp, Takuto Takeuchi, Koji Yamada, Kohei Atsuji, Yuta Asayama, Kengo Suzuki, and Claire L Kruger in Toxicology Research and Application

Published
2018
Full Text
View/download PDF

24. GRAS notification: a case study: a number of GRAS ingredients have entered the marketplace. Their allergenic potential is a concern. Here is a look at how this issue was addressed in a novel way for lactoferrin, a milk-derived protein

Author

Kruger, Claire L.

Subjects
Lactoferrins -- Case studies, Iron proteins -- Case studies, Business, Food and beverage industries
Abstract

Several years ago, the FDA made a fundamental change in how it allowed new food ingredients to enter the market. (See 'GRAS Ingredients in the 21st Century,' Prepared Foods, May [...]

Published
2004

28. Human Health Effects Assays

Author

Fradkin, Larry, Sonich-Mullin, Cynthia, Cerny, Mary, Kruger, Claire, and Cavender, Finis

Published
1989

31. Safety evaluation of galacto-oligosaccharides

Author

Zhou, Yuting, primary, Kruger, Claire, additional, Ravi, GS, additional, Kumar, DP Santhosh, additional, Vijayasarathi, SK, additional, Lavingia, Mayuri, additional, Chen, Xiaoyan, additional, and Ambriz, Pamela, additional

Published
2017
Full Text
View/download PDF

38. Establishing Limits for THC Content in Hemp-Derived Foods.

Author

Kruger, Claire and Lodder, Robert

Abstract

The article reports on a growing number of foods being formulated to include oils and seeds from the hemp plant due to the favorable nutrient profile of this plant. Topics covered include a bill introduced by U.S. Senator Mitch McConnell that would allow states and tribes to regulate hemp production, and the need to establish limits tetrahydro-cannabinol (THC) contents in hemp-derived foods

Published
2018

39. Filtering Scientific Noise: Colorectal Cancer and Red/Processed Meat.

Author

Clemens, Roger, Sloan, A. Elizabeth, and Kruger, Claire

Subjects
MEAT, COLON cancer risk factors, DOSE-response relationship in biochemistry, CANCER-related mortality
Abstract

The article offers information the effect of increase red and processed meat consumption on the risk of developing colorectal cancer. Topics discussed include dose-response meta-analyses in research without considering biologic plausibility, distinction between hazard and risk and consideration of an agent as a cancer hazard, and facts about cancer by National Cancer Institute (NCI) and World Health Organization (WHO) such as number of cases and deaths due to cancer.

Published
2016

40. Understanding the Difference Between Hazard and Risk.

Author

Clemens, Roger, Hayes, A. Wallace, and Kruger, Claire

Subjects
FOOD safety, HAZARDS, RISK, DRUG dosage, FOOD production
Abstract

The article offers the author's insights on the importance of understanding the relationship between hazard and risk in the safety of food supply and medications. The principles discussed in understanding the hazard and risk relationship include the significance of dosage, the critical of timing, the difference among people, and things change. Also mentioned are the negative aspects of the food supply, food ingredients, and food processing.

Published
2016

41. Exceptions to the New Dietary Ingredient Notification Requirement: Utilizing GRAS as a Path Forward.

Author

Kruger, Claire L., Booth, Nancy, and Hayes, A. Wallace

Subjects
*GUIDELINES, *DIETARY supplements policy, *INGREDIENT substitutions (Cooking), *FOOD industry, *ARTIFICIAL foods
Abstract

The artice discusses the draft guidance issued by the U.S. Food and Drug Administration (FDA) in the "Federal Register" notice on July 5, 2011 for food industry. It says that the guidance provides detailed information on the submission of New Dietary Ingredient Notifications (NDINs). It mentions that synthetic compounds and probiotics from animal or human origin are not included in the requirement because they are qualified as Generally Recognized as Safe (GRAS).

Published
2012

42. Policing Ourselves: Is GRAS Robust Enough?

Author

Kruger, Claire L., Booth, Nancy, and Hayes, A. Wallace

Subjects
*FOOD safety, *FOOD handling, *FOOD industry, *FOOD additives
Abstract

The article presents an analysis regarding the robustness of the Generally Recognized as Safe (GRAS) process in the U.S. It provides an overview of the comparison among three processes including the GRAS process, the European Food Safety Authority (EFSA) and the Joint Expert Committee on Food Additives (JECFA). It also notes that there is a robustness and transparency of the GRAS process because it relies on common knowledge about the safety of the substance for its intended use.

Published
2011

43. Guiding Product Recall Strategy with Probabilistic Modeling.

Author

Conze, Dietrich B. and Kruger, Claire

Subjects
*FOOD labeling laws, *HEALTH risk assessment, *FOOD allergy prevention, *FOOD inspection, *FOOD contamination prevention
Abstract

The article focuses on a recall strategy of conducting a health hazard evaluation as guided by the Food Allergen Labeling and Consumer Protection Act (FALCPA) of 2004, which aims in protecting consumers from the food allergens. It discusses the definition of food adulteration and its serious effects. It also discusses the importance of quantitative risk assessments that provides information on the chance of illness or death after being exposed to an allergen.

Published
2013

44. Prophylactic antibiotics and corticosteroid prescribing in palliative medicine: retrospective study.

Author

Kruger C, Lannon C, Harnett I, and Murtagh C

Abstract

Objectives: To investigate whether patients under the care of the community specialist palliative care team receiving steroids are at increased risk of infection.To identify other risk factors that predispose community palliative care patients to infection., Methods: A retrospective chart review of all patients referred to a community specialist palliative care service., Results: 177 adult patients were referred to the community specialist palliative care service. Corticosteroids were significantly associated with infection. 39% of patients who received an oral steroid had infection compared with 22% of those who did not receive steroids (OR 2.6 (95% CI 1.07 to 3), RR 1.78 (95% CI 1.08 to 2.9), p=0.02). Regular opioids were significantly associated with infection. 33% of patients receiving a regular opioid had an infection compared with 15% of those not receiving a regular opioid (OR 2.69 (95% CI 1.26 to 5.7), RR 2.06 (95% CI 1.2 to 3.8), p=0.008). Male gender, lung disease, diabetes and immunosuppressive therapies were associated with an increased rate of infection but were not statistically significant., Conclusions: Oral corticosteroids were associated with a significantly increased infection rate in a community palliative care population. These patients could potentially benefit from antibiotic prophylaxis while receiving corticosteroids., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.)

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results